IL6 and cancer: Taken together, it is likely that in tobacco-related cancer of the airways, the respiratory mucosal inflammation characterized by high IL-6 and cytokines release, frequently associated to cancer growth and progression, may contribute to COVID-19 infection and severity because of a pre-existent unbalanced host immune response.